192 related articles for article (PubMed ID: 12195785)
21. Peripheral blood lymphocyte apoptosis and circulating dendritic cells in patients with systemic lupus erythematosus: correlation with immunological status and disease-related symptoms.
Robak E; Sysa-Jedrzejowska A; Robak T; Smolewski P
Clin Rheumatol; 2006 Mar; 25(2):225-33. PubMed ID: 16432661
[TBL] [Abstract][Full Text] [Related]
22. Autoantibody-Positive Healthy Individuals Display Unique Immune Profiles That May Regulate Autoimmunity.
Slight-Webb S; Lu R; Ritterhouse LL; Munroe ME; Maecker HT; Fathman CG; Utz PJ; Merrill JT; Guthridge JM; James JA
Arthritis Rheumatol; 2016 Oct; 68(10):2492-502. PubMed ID: 27059145
[TBL] [Abstract][Full Text] [Related]
23. Natural killer T cells in families of patients with systemic lupus erythematosus: their possible role in regulation of IGG production.
Green MR; Kennell AS; Larche MJ; Seifert MH; Isenberg DA; Salaman MR
Arthritis Rheum; 2007 Jan; 56(1):303-10. PubMed ID: 17195234
[TBL] [Abstract][Full Text] [Related]
24. Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha.
Habib HM; Taher TE; Isenberg DA; Mageed RA
Scand J Rheumatol; 2009; 38(2):112-20. PubMed ID: 19110660
[TBL] [Abstract][Full Text] [Related]
25. High occurrence of in vitro apoptosis of lymphocytes induced by serum from systemic lupus erythematosus patients is associated with increased serum levels of anti-C1q autoantibodies.
Hasan SI; Mohd Ashari NS; Mohd Daud K; Che Husin CM
Int J Rheum Dis; 2013 Aug; 16(4):430-6. PubMed ID: 23992264
[TBL] [Abstract][Full Text] [Related]
26. Increased interleukin 21 and follicular helper T-like cells and reduced interleukin 10+ B cells in patients with new-onset systemic lupus erythematosus.
Wang L; Zhao P; Ma L; Shan Y; Jiang Z; Wang J; Jiang Y
J Rheumatol; 2014 Sep; 41(9):1781-92. PubMed ID: 25028374
[TBL] [Abstract][Full Text] [Related]
27. Assessment of Be1 and Be2 cells in systemic lupus erythematosus indicates elevated interleukin-10 producing CD5+ B cells.
Amel Kashipaz MR; Huggins ML; Lanyon P; Robins A; Powell RJ; Todd I
Lupus; 2003; 12(5):356-63. PubMed ID: 12765298
[TBL] [Abstract][Full Text] [Related]
28. Aberrant expression of regulatory cytokine IL-35 in patients with systemic lupus erythematosus.
Cai Z; Wong CK; Kam NW; Dong J; Jiao D; Chu M; Lam CW; Tam LS
Lupus; 2015 Oct; 24(12):1257-66. PubMed ID: 25966926
[TBL] [Abstract][Full Text] [Related]
29. Autoantibodies and self-reported health complaints in relatives of systemic lupus erythematosus patients: a community based approach.
Laustrup H; Heegaard NH; Voss A; Green A; Lillevang ST; Junker P
Lupus; 2004; 13(10):792-9. PubMed ID: 15540512
[TBL] [Abstract][Full Text] [Related]
30. Abnormalities in CD69 expression, cytosolic pH and Ca2+ during activation of lymphocytes from patients with systemic lupus erythematosus.
Portales-Pérez D; González-Amaro R; Abud-Mendoza C; Sánchez-Armáss S
Lupus; 1997; 6(1):48-56. PubMed ID: 9116719
[TBL] [Abstract][Full Text] [Related]
31. Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-) and CD8(+) T cells in systemic lupus erythematosus.
Amel-Kashipaz MR; Huggins ML; Lanyon P; Robins A; Todd I; Powell RJ
J Autoimmun; 2001 Sep; 17(2):155-63. PubMed ID: 11591124
[TBL] [Abstract][Full Text] [Related]
32. Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients.
Pavón EJ; Zumaquero E; Rosal-Vela A; Khoo KM; Cerezo-Wallis D; García-Rodríguez S; Carrascal M; Abian J; Graeff R; Callejas-Rubio JL; Ortego-Centeno N; Malavasi F; Zubiaur M; Sancho J
Cytokine; 2013 May; 62(2):232-43. PubMed ID: 23538292
[TBL] [Abstract][Full Text] [Related]
33. Impact of CD4+CD25high regulatory T-cells and FoxP3 expression in the peripheral blood of patients with systemic lupus erythematosus.
Atfy M; Amr GE; Elnaggar AM; Labib HA; Esh A; Elokely AM
Egypt J Immunol; 2009; 16(1):117-26. PubMed ID: 20726328
[TBL] [Abstract][Full Text] [Related]
34. Lymphocyte apoptosis in systemic lupus erythematosus: relationships with Fas expression, serum soluble Fas and disease activity.
Courtney PA; Crockard AD; Williamson K; McConnell J; Kennedy RJ; Bell AL
Lupus; 1999; 8(7):508-13. PubMed ID: 10483027
[TBL] [Abstract][Full Text] [Related]
35. The role of microRNA-31 and microRNA-21 as regulatory biomarkers in the activation of T lymphocytes of Egyptian lupus patients.
Amr KS; Bayoumi FS; Elgengehy FT; Abdallah SO; Ahmed HH; Eissa E
Rheumatol Int; 2016 Nov; 36(11):1617-1625. PubMed ID: 27510529
[TBL] [Abstract][Full Text] [Related]
36. Alterations in T-lymphocyte sub-set profiles and cytokine secretion by PBMC of systemic lupus erythematosus patients upon in vitro exposure to organochlorine pesticides.
Dar SA; Das S; Ramachandran VG; Bhattacharya SN; Mustafa MD; Banerjee BD; Verma P
J Immunotoxicol; 2012; 9(1):85-95. PubMed ID: 22214240
[TBL] [Abstract][Full Text] [Related]
37. [Abnormal signaling activity of phosphatidylinositol 3-kinase pathway in peripheral blood T cells from patients with systemic lupus erythematosus].
Liang LQ; Zhan ZP; Xu HS; Yang XY; Ye YJ; Lian F; Qiu Q
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2036-40. PubMed ID: 19080430
[TBL] [Abstract][Full Text] [Related]
38. Lymphocyte apoptosis and macrophage function: correlation with disease activity in systemic lupus erythematosus.
Jin O; Sun LY; Zhou KX; Zhang XS; Feng XB; Mok MY; Lau CS
Clin Rheumatol; 2005 Apr; 24(2):107-10. PubMed ID: 15818511
[TBL] [Abstract][Full Text] [Related]
39. Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus.
Ren Y; Tang J; Mok MY; Chan AW; Wu A; Lau CS
Arthritis Rheum; 2003 Oct; 48(10):2888-97. PubMed ID: 14558095
[TBL] [Abstract][Full Text] [Related]
40. Circulating CXCR5+CD4+helper T cells in systemic lupus erythematosus patients share phenotypic properties with germinal center follicular helper T cells and promote antibody production.
Zhang X; Lindwall E; Gauthier C; Lyman J; Spencer N; Alarakhia A; Fraser A; Ing S; Chen M; Webb-Detiege T; Zakem J; Davis W; Choi YS; Quinet R
Lupus; 2015 Aug; 24(9):909-17. PubMed ID: 25654980
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
